Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis.

Javed F, Tamisier R, Pepin JL, Cowie MR, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Simonds AK, Somers VK, Teschler H, Levy P, Armitstead J, Woehrle H.

Respirology. 2019 Jun 20. doi: 10.1111/resp.13613. [Epub ahead of print]

PMID:
31218793
2.

Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

Backs D, Saglam I, Löffler C, Ihne S, Morbach C, Brenner S, Angermann C, Ertl G, Frantz S, Störk S, Knop S, Güder G.

Oncotarget. 2019 May 7;10(34):3154-3165. doi: 10.18632/oncotarget.26872. eCollection 2019 May 7.

3.

Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial.

Schulz SM, Ritter O, Zniva R, Nordbeck P, Wacker C, Jack M, Groschup G, Deneke T, Puppe F, Ertl G, Angermann C, Störk S, Pauli P.

Eur Heart J. 2019 Apr 8. pii: ehz134. doi: 10.1093/eurheartj/ehz134. [Epub ahead of print]

PMID:
30957867
4.

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.

Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen HD, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F.

ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.

5.

The omega-3 index in patients with heart failure: A prospective cohort study.

Berliner D, Mattern S, Wellige M, Malsch C, Güder G, Brenner S, Morbach C, Deubner N, Breunig M, Kiefl R, Angermann CE, Ertl G, von Schacky C, Störk S.

Prostaglandins Leukot Essent Fatty Acids. 2019 Jan;140:34-41. doi: 10.1016/j.plefa.2018.11.012. Epub 2018 Nov 28.

PMID:
30553401
6.

Depression, Anxiety, and Cognitive Impairment : Comorbid Mental Health Disorders in Heart Failure.

Angermann CE, Ertl G.

Curr Heart Fail Rep. 2018 Dec;15(6):398-410. doi: 10.1007/s11897-018-0414-8. Review.

PMID:
30402659
7.

[Telemonitoring and pulmonary artery pressure-guided treatment of heart failure].

Angermann CE, Rosenkranz S.

Internist (Berl). 2018 Oct;59(10):1041-1053. doi: 10.1007/s00108-018-0495-1. Review. German.

PMID:
30238134
8.

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, Winkler S, Vettorazzi E, Bruch L, Oeff M, Zugck C, Doerr G, Naegele H, Störk S, Butter C, Sechtem U, Angermann C, Gola G, Prondzinsky R, Edelmann F, Spethmann S, Schellong SM, Schulze PC, Bauersachs J, Wellge B, Schoebel C, Tajsic M, Dreger H, Anker SD, Stangl K.

Lancet. 2018 Sep 22;392(10152):1047-1057. doi: 10.1016/S0140-6736(18)31880-4. Epub 2018 Aug 25.

PMID:
30153985
9.

Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression.

Piepenburg SM, Faller H, Störk S, Ertl G, Angermann CE.

Clin Res Cardiol. 2019 Mar;108(3):244-253. doi: 10.1007/s00392-018-1348-6. Epub 2018 Aug 10.

PMID:
30097684
10.

The Comprehensive Heart Failure Centre in Würzburg, Germany.

Angermann CE, Frantz S, Maack C.

Eur Heart J. 2018 May 21;39(20):1757-1760. doi: 10.1093/eurheartj/ehy202. No abstract available.

PMID:
29788301
11.

Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Köhler F, Rosenkranz S, Tschöpe C, Adamson PB, Böhm M.

Clin Res Cardiol. 2018 Nov;107(11):991-1002. doi: 10.1007/s00392-018-1281-8. Epub 2018 May 19.

PMID:
29777373
12.

CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients.

Kittel-Schneider S, Kaspar M, Berliner D, Weber H, Deckert J, Ertl G, Störk S, Angermann C, Reif A.

Brain Behav Immun. 2018 Jul;71:133-141. doi: 10.1016/j.bbi.2018.04.002. Epub 2018 Apr 5.

PMID:
29627531
13.

Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF.

Cowie MR, Woehrle H, Wegscheider K, Vettorazzi E, Lezius S, Koenig W, Weidemann F, Smith G, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H.

Eur J Heart Fail. 2018 Mar;20(3):536-544. doi: 10.1002/ejhf.1048. Epub 2017 Nov 30.

14.

Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.

Morbach C, Buck T, Rost C, Peter S, Günther S, Störk S, Prettin C, Erbel R, Ertl G, Angermann CE; Handheld-BNP Research Network.

Clin Res Cardiol. 2018 Feb;107(2):95-107. doi: 10.1007/s00392-017-1181-3. Epub 2017 Nov 15.

PMID:
29143161
15.

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J.

Eur Heart J. 2017 Sep 14;38(35):2671-2679. doi: 10.1093/eurheartj/ehx355.

16.

Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis.

Woehrle H, Cowie MR, Eulenburg C, Suling A, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H, Wegscheider K.

Eur Respir J. 2017 Aug 31;50(2). pii: 1601692. doi: 10.1183/13993003.01692-2016. Print 2017 Aug.

17.

Simple screening tools predict death and cardiovascular events in patients with rheumatic disease.

Breunig M, Kleinert S, Lehmann S, Kneitz C, Feuchtenberger M, Tony HP, Angermann CE, Ertl G, Störk S.

Scand J Rheumatol. 2018 Mar;47(2):102-109. doi: 10.1080/03009742.2017.1337924. Epub 2017 Aug 16.

PMID:
28812405
18.

Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.

Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE; INH Study Group and the Competence Network Heart Failure.

Eur J Heart Fail. 2017 Sep;19(9):1166-1175. doi: 10.1002/ejhf.859. Epub 2017 May 17.

19.

Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure.

Lüers C, Edelmann F, Wachter R, Pieske B, Mende M, Angermann C, Ertl G, Düngen HD, Störk S.

Clin Cardiol. 2017 Sep;40(9):667-673. doi: 10.1002/clc.22710. Epub 2017 May 3.

20.

Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.

von Haehling S, Gremmler U, Krumm M, Mibach F, Schön N, Taggeselle J, Dahm JB, Angermann CE.

Clin Res Cardiol. 2017 Jun;106(6):436-443. doi: 10.1007/s00392-016-1073-y. Epub 2017 Feb 22.

21.

[Cardiac remodeling after myocardial infarction : Clinical practice update].

Ertl G, Brenner S, Angermann CE.

Herz. 2017 Feb;42(1):107-120. doi: 10.1007/s00059-016-4530-5. Review. German.

PMID:
28105480
22.

Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling.

Wallenborn J, Marx A, Störk S, Güder G, Brenner S, Ertl G, Angermann CE.

Int J Cardiol. 2017 Apr 1;232:199-207. doi: 10.1016/j.ijcard.2017.01.021. Epub 2017 Jan 5.

PMID:
28094131
23.

A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.

Angermann CE, Kaspar M, Marx A, Kittel-Schneider S, Menhofer D, Störk S, Ertl G, Domschke K, Deckert J, Reif A.

Eur J Heart Fail. 2017 Mar;19(3):314-323. doi: 10.1002/ejhf.706. Epub 2016 Dec 18.

24.

Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.

Brenner S, Christa M, Berliner D, Deubner N, Ertl G, Held M, Marx A, Angermann CE, Störk S, Rutten FH, Güder G.

Int J Cardiol. 2017 Jan 15;227:727-733. doi: 10.1016/j.ijcard.2016.10.071. Epub 2016 Oct 28.

PMID:
27816302
25.

Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis.

Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H, Cowie MR.

Lancet Respir Med. 2016 Nov;4(11):873-881. doi: 10.1016/S2213-2600(16)30244-2. Epub 2016 Aug 31.

26.
27.

Escitalopram and Outcomes Among Patients With Depression and Heart Failure-Reply.

Angermann CE, Deckert J, Ertl G.

JAMA. 2016 Oct 11;316(14):1494-1495. doi: 10.1001/jama.2016.13888. No abstract available.

PMID:
27727381
28.

[Depression and heart failure - a dangerous combination].

Piepenburg SM, Ertl G, Angermann CE.

Dtsch Med Wochenschr. 2016 Aug;141(17):1222-7. doi: 10.1055/s-0042-108681. Epub 2016 Aug 24. German.

PMID:
27557068
29.

Data Linkage from Clinical to Study Databases via an R Data Warehouse User Interface. Experiences from a Large Clinical Follow-up Study.

Kaspar M, Ertl M, Fette G, Dietrich G, Toepfer M, Angermann C, Störk S, Puppe F.

Methods Inf Med. 2016 Aug 5;55(4):381-6. doi: 10.3414/ME15-02-0015. Epub 2016 Jul 13.

PMID:
27405886
30.

Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.

Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G; MOOD-HF Study Investigators and Committee Members.

JAMA. 2016 Jun 28;315(24):2683-93. doi: 10.1001/jama.2016.7635.

PMID:
27367876
31.

High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure.

Hammer F, Deutschbein T, Marx A, Güder G, Michalski R, Ertl G, Allolio B, Angermann CE, Störk S, Fassnacht M.

Int J Cardiol. 2016 Jan 15;203:69-73. doi: 10.1016/j.ijcard.2015.10.084. Epub 2015 Oct 20.

PMID:
26492313
32.

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure.

Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H.

N Engl J Med. 2015 Sep 17;373(12):1095-105. doi: 10.1056/NEJMoa1506459. Epub 2015 Sep 1.

33.

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.

Haghikia A, Podewski E, Berliner D, Sonnenschein K, Fischer D, Angermann CE, Böhm M, Röntgen P, Bauersachs J, Hilfiker-Kleiner D.

Clin Res Cardiol. 2015 Nov;104(11):911-7. doi: 10.1007/s00392-015-0869-5. Epub 2015 May 31.

34.

Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure.

Piepenburg SM, Faller H, Gelbrich G, Störk S, Warrings B, Ertl G, Angermann CE.

Circ Heart Fail. 2015 May;8(3):464-72. doi: 10.1161/CIRCHEARTFAILURE.114.001488. Epub 2015 Apr 15.

PMID:
25878325
35.

[Acute heart failure - a unique challenge].

Angermann CE, Ertl G.

Dtsch Med Wochenschr. 2015 Mar;140(6):395-401. doi: 10.1055/s-0041-100708. Epub 2015 Mar 16. German.

PMID:
25774728
36.

Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?

Faller H, Störk S, Gelbrich G, Schowalter M, Ertl G, Angermann CE.

J Psychosom Res. 2015 Jun;78(6):569-72. doi: 10.1016/j.jpsychores.2015.02.015. Epub 2015 Mar 7.

PMID:
25770643
37.

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry.

Filippatos G, Khan SS, Ambrosy AP, Cleland JG, Collins SP, Lam CS, Angermann CE, Ertl G, Dahlström U, Hu D, Dickstein K, Perrone SV, Ghadanfar M, Bermann G, Noe A, Schweizer A, Maier T, Gheorghiade M.

Eur J Heart Fail. 2015 May;17(5):527-33. doi: 10.1002/ejhf.262. Epub 2015 Mar 10.

38.

Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.

Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.

Eur J Heart Fail. 2015 Apr;17(4):442-52. doi: 10.1002/ejhf.252. Epub 2015 Mar 2.

39.

Reverse epidemiology in different stages of heart failure.

Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, Maisch B, Prettin C, Brenner S, Morbach C, Berliner D, Deubner N, Ertl G, Angermann CE, Störk S; Competence Network Heart Failure Germany.

Int J Cardiol. 2015 Apr 1;184:216-24. doi: 10.1016/j.ijcard.2015.02.009. Epub 2015 Feb 10.

PMID:
25710785
40.

Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.

Güder G, Hammer F, Deutschbein T, Brenner S, Berliner D, Deubner N, Bidlingmaier M, Ertl G, Allolio B, Angermann CE, Fassnacht M, Störk S.

J Card Fail. 2015 Mar;21(3):208-16. doi: 10.1016/j.cardfail.2014.12.011. Epub 2015 Jan 5.

PMID:
25573831
41.

Clinical characteristics, treatment and survival in patients with systolic heart failure--comparative assessment of a Chinese and a German cohort.

Cui X, Kaspar M, Zhu H, Störk S, Ertl G, Zhou J, Ge J, Angermann CE.

Int J Cardiol. 2014 Oct 20;176(3):1388-90. doi: 10.1016/j.ijcard.2014.08.026. Epub 2014 Aug 10. No abstract available.

PMID:
25156836
42.

Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study.

Gelbrich G, Störk S, Kreißl-Kemmer S, Faller H, Prettin C, Heuschmann PU, Ertl G, Angermann CE.

Eur J Heart Fail. 2014 Oct;16(10):1133-41. doi: 10.1002/ejhf.150. Epub 2014 Aug 20.

43.

Position paper on the importance of psychosocial factors in cardiology: Update 2013.

Ladwig KH, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, Fritzsche K, Haass M, Jordan J, Jünger J, Kindermann I, Köllner V, Kuhn B, Scherer M, Seyfarth M, Völler H, Waller C, Herrmann-Lingen C.

Ger Med Sci. 2014 May 7;12:Doc09. doi: 10.3205/000194. eCollection 2014.

44.

[Holistic therapy of chronic heart failure].

Feldmann C, Ertl G, Angermann CE.

Internist (Berl). 2014 Jun;55(6):676-86. doi: 10.1007/s00108-013-3427-0. German.

PMID:
24806269
45.

Complement C3c as a biomarker in heart failure.

Frey A, Ertl G, Angermann CE, Hofmann U, Störk S, Frantz S.

Mediators Inflamm. 2013;2013:716902. doi: 10.1155/2013/716902. Epub 2013 Dec 30.

46.

Comorbid depression in heart failure.

Wallenborn J, Angermann CE.

Herz. 2013 Sep;38(6):587-96. doi: 10.1007/s00059-013-3886-z.

PMID:
23900388
47.

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.

Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA.

Eur Heart J. 2014 Apr;35(16):1069-77. doi: 10.1093/eurheartj/eht251. Epub 2013 Jul 12.

PMID:
23853074
48.

Reply to: Risk assessment of depression by questionnaire for patients with heart failure.

Lossnitzer N, Herzog W, Gelbrich G, Störk S, Wild B, Ertl G, Angermann CE.

Int J Cardiol. 2013 Oct 3;168(3):3129. doi: 10.1016/j.ijcard.2013.04.036. Epub 2013 May 1. No abstract available.

PMID:
23642818
49.

Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure.

Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds A, Somers VK, Zannad F, Teschler H.

Eur J Heart Fail. 2013 Aug;15(8):937-43. doi: 10.1093/eurjhf/hft051. Epub 2013 Mar 27.

50.

Airway obstruction in systolic heart failure--COPD or congestion?

Brenner S, Güder G, Berliner D, Deubner N, Fröhlich K, Ertl G, Jany B, Angermann CE, Störk S.

Int J Cardiol. 2013 Oct 3;168(3):1910-6. doi: 10.1016/j.ijcard.2012.12.083. Epub 2013 Jan 29.

PMID:
23369673

Supplemental Content

Loading ...
Support Center